For healthcare professionals only

News Shortcuts from other journals

HPV vaccine highly effective in uninfected young women

BMJ 2007; 334 doi: (Published 17 May 2007) Cite this as: BMJ 2007;334:1028

Merck's new quadrivalent vaccine against human papillomavirus (HPV) was highly effective against precancerous cervical lesions and anogenital warts in two recent trials. In young women not infected with the vaccine serotypes, vaccine efficacy was 90-100% in both trials over three years. However, the vaccine was …

View Full Text

Log in

Log in through your institution


* For online subscription